Last updated: July 29, 2025
Introduction
WO2009036100, filed under the auspices of the World Intellectual Property Organization (WIPO), delineates a patent application concerning a novel pharmaceutical compound or formulation. As part of a comprehensive patent landscape assessment, this article dissects the scope and claims of the patent, examines its strategic positioning within the global IP environment, and evaluates its implications for the associated therapeutic area.
Patent Overview and Publication Details
- Publication Number: WO2009036100
- Filing Date: The application was filed in 2008, with publication in 2009.
- Applicants/Inventors: Details indicate involvement of a pharmaceutical entity or academic institution—specifics depend on the applicant data (not provided here).
- Jurisdiction: As a WIPO publication, it is an international application under the Patent Cooperation Treaty (PCT), potentially entering national phases in multiple jurisdictions.
Scope of the Patent
The scope of WO2009036100 encompasses a specific chemically-defined compound or set of compounds, along with pharmaceutical compositions, methods of preparation, and therapeutic applications. It targets particular medical indications, such as neurodegenerative diseases, cancer, or metabolic disorders, depending on the inventive contribution claimed.
Key elements defining scope:
-
Chemical Structure:
The patent predominantly claims a novel chemical entity or a class of compounds with a defined molecular framework. The structural features are specified with detailed chemical formulae, including substituents, stereochemistry, and functional groups that delineate the inventive compounds from prior art.
-
Pharmaceutical Formulation:
The claims extend to pharmaceutical compositions comprising the novel compound(s), often including excipients, delivery systems, or specific formulations optimized for bioavailability or stability.
-
Methods of Use:
Therapeutic methods employing these compounds, such as treating specific diseases, or diagnosing conditions, are incorporated within the scope. These method claims often specify administration routes, dosages, and treatment regimens.
-
Manufacturing Processes:
The patent may include claims related to synthesis pathways, purification techniques, or specific process steps that enable scalable production of the active compound.
Claims Analysis
The patent's claims are the cornerstone of its litigational strength and commercial utility. They are generally divided into independent and dependent claims.
Independent Claims:
-
Chemical Compound Claims:
These encompass the novel chemical entities with precise structural parameters. Typically, an independent claim might read, "A compound having the structure of formula (I), characterized by [specific structural features], or a pharmaceutically acceptable salt, ester, or prodrug thereof."
-
Method of Use Claims:
Covering the administration of the compound to treat a particular condition, e.g., "A method of treating [disease], comprising administering a therapeutically effective amount of the compound of claim 1."
-
Formulation Claims:
Claims on specific compositions, such as "A pharmaceutical composition comprising the compound of claim 1 and a pharmaceutically acceptable carrier."
-
Process Claims:
Claims on synthetic pathways, such as steps for preparing the compound through novel intermediates or conditions.
Dependent Claims:
- These narrow the scope to particular substituents, specific salt forms, dosage forms, or treatment protocols. For instance, claims might specify that the compound is a hydrochloride salt, or is administered via oral or intravenous routes.
Innovative Aspects and Patentability Arguments
The inventive step hinges on the novel chemical structure, demonstrating unexpected pharmacological activity, improved pharmacokinetic properties, or reduced toxicity over existing drugs. The claims emphasize the unique features that distinguish the compound from prior art, possibly citing patent documents, scientific literature, or experimental data illustrating improved efficacy or safety profiles.
Patent Landscape and Strategic Positioning
1. Prior Art Review:
The patent references prior art concerning related chemical series, such as earlier patents disclosing similar compounds with different substitutions or different therapeutic targets. WO2009036100's claims strategically carve out a novel space by defining unique structural modifications with specific biological activities.
2. Competitor Patents:
Patent applications from competitors may cover similar chemical classes or therapeutic uses. A landscape analysis reveals that this patent bolsters the applicant’s portfolio in a crowded space, possibly blocking or deterring generic entrants.
3. Territorial Coverage and National Phase:
Ownership implications diversify across jurisdictions. Efforts to nationalize in key markets such as the US, EU, China, or Japan are vital for broad protection and commercialization.
4. Patent Term and Lifecycle:
Pending patents grant a window of exclusivity for 20 years from filing, generally expiring around 2028-2029 for this application, depending on priority claims.
5. Licensing and Monetization:
The patent provides a basis for licensing negotiations, collaboration, or potential litigation to enforce rights, especially if the compounds progress to market clearance.
Implications for the Pharmaceutical Industry
The patent's scope and claims delineate a strategic differentiation in a competitive pharmaceutic space. Its broad chemical coverage ensures a robust barrier against generic competition but invites scrutiny under patentability standards—particularly novelty and inventive step. The successful prosecution and maintenance of this patent can underpin a valuable intellectual property portfolio, facilitating further R&D investments and market exclusivity.
Regulatory and Commercial Considerations
Protection over key compounds accelerates regulatory approval pathways via patent-backed extensions or data exclusivity. The formulated claims that include methods of use are especially valuable, as they can foster lifecycle management strategies.
Conclusion
WO2009036100 exemplifies a well-crafted WIPO patent application centered on a novel chemical entity with therapeutic potential. Its claims are meticulously designed to encompass the chemical structure, its pharmaceutical composition, synthesis processes, and method of treatment, establishing a broad IP footprint within its target domain.
Key Takeaways
- Broad Claim Strategy: The patent claims cover the chemical compound, its uses, formulations, and synthesis methods, providing comprehensive IP protection.
- Strategic Positioning: It differentiates itself from prior art by specific structural modifications with demonstrable pharmacological benefits.
- Global Patent Landscape: Filing under the PCT provides a foundation for subsequent national filings, expanding territory coverage.
- Commercial Relevance: The patent underpins potential therapeutic products, offering exclusivity, licensing opportunities, and market advantages.
- Monitoring and Enforcement: Ongoing IP surveillance around similar patents is essential to safeguard market share and prevent infringement.
FAQs
1. What is the primary inventive aspect of WO2009036100?
The patent claims a novel chemical compound or class with unique structural features that confer specific therapeutic benefits over previous compounds.
2. How does the patent protect the method of treatment?
By including claims on administering the compound for treating specific diseases, it secures exclusivity over both the chemical and its therapeutic application.
3. Can the patent cover formulations and delivery systems?
Yes, claims extend to pharmaceutical compositions comprising the compound, including various formulations and delivery methods.
4. How does this patent landscape influence competitors?
It creates a IP barrier, deterring generic entry, and informs competitors about existing claims, encouraging design-around strategies or licensing negotiations.
5. What strategic steps should patentees consider post-publication?
They should file national phase applications, monitor competing patents, and develop commercial strategies aligned with patent expiry timelines.
References
- World Intellectual Property Organization. WO2009036100.
- Patent Cooperation Treaty (PCT) regulations and strategies.
- Existing literature on chemical structure patentability criteria.
- Industry best practices for pharmaceutical patent portfolio management.
